|
  
- 积分
- 635
- 威望
- 635
- 包包
- 192
|

本帖最后由 flydayzhu 于 2010-8-28 16:37 编辑
' r4 T3 v- g0 J3 l/ p- W1 K( k+ Q/ Q2 I* C
麻烦大家了,最好是能够提供杂志版的,看着相对舒服点,谢谢~+ x& ~% j5 X6 V# Q
2 R" l, y5 \9 K- ~9 j% f1.Promotion of direct reprogramming by transformation-deficient Myc.& Y: d8 Z* k3 B& ]5 u7 j, y
Nakagawa M, Takizawa N, Narita M, Ichisaka T, Yamanaka S.7 `- l& K$ ~; h# g
3 l" g: V5 X+ ^4 hCenter for iPS Cell Research and Application, Kyoto University, Kyoto 606-8507, Japan. nakagawa@cira.kyoto-u.ac.jp
$ y& } Y* z2 A5 h3 rhttp://www.ncbi.nlm.nih.gov/pubmed/20660764
1 N7 T- O0 m3 ~% M: K
: }1 r# j9 r) P+ m9 m2.Stem Cells. 2010 Aug;28(8):1349-54.
3 S5 g9 D2 Y9 S5 t8 z: ~Aberrant epigenetic silencing of tumor suppressor genes is reversed by direct reprogramming.
: L/ f0 n% g" x* {% d7 {+ \Ron-Bigger S, Bar-Nur O, Isaac S, Bocker M, Lyko F, Eden A.8 \9 ^% n" d8 |* b3 V
6 F- Y6 W* X: l+ R: D5 B
Departments of Cell and Developmental Biology, Silberman Institute of Life Sciences, The Hebrew University of Jerusalem, Jerusalem, Israel.4 u2 }3 p/ q4 c5 W% T
http://www.ncbi.nlm.nih.gov/pubmed/20572015
0 S* n/ Q5 P O s. I: L w0 X% p. k3 b; |, H3 b" g+ Y
3.Nat Biotechnol. 2010 May;28(5):521-6. Epub 2010 May 2.( `% [) U8 c+ _* r/ [
Dynamic single-cell imaging of direct reprogramming reveals an early specifying event.: j6 R+ l$ y/ \( F4 q& k
Smith ZD, Nachman I, Regev A, Meissner A., [$ I S" T; ~" }4 i
: ^( y$ L9 B! ?% z8 n; \
Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
5 Y& p" `4 Z- e, ~% f3 m, gComment in:
( B/ ?6 D" s4 i5 b# N& F4 _ Q# {& ~. ^1 ?# o1 T5 C3 }' f
Regen Med. 2010 Jul;5(4):501-3.1 r1 R. }( e2 ^
http://www.ncbi.nlm.nih.gov/pubmed/204364600 B% j& T4 Q( a* O2 p4 H9 p/ h$ V* p
Y2 w: d- k0 r) n; t
4.PLoS One. 2010 Mar 24;5(3):e9838.' R: x0 v6 r; |2 t& ^5 k! H
Direct reprogramming of rat neural precursor cells and fibroblasts into pluripotent stem cells.
5 b/ u! q4 Z8 m3 \) FChang MY, Kim D, Kim CH, Kang HC, Yang E, Moon JI, Ko S, Park J, Park KS, Lee KA, Hwang DY, Chung Y, Lanza R, Kim KS.
: L" J$ d/ \* G% Z; Q" H! G- h: X) x% u1 V
Molecular Neurobiology Laboratory, McLean Hospital, Harvard Medical School, Belmont, Massachusetts, United States of America. k9 a: Q7 R# {9 ?" o
http://www.ncbi.nlm.nih.gov/pubmed/20352099
- K! Y3 C7 w* g# L( T1 V% z) q7 h7 q8 }7 T# C
5.Dev Growth Differ. 2010 Apr;52(3):319-33. Epub 2010 Mar 7.- U& s# w, ~& ?6 r; N4 e7 U( X. _
Direct reprogramming 101.; q2 Y* m* K; v% N& o3 a* T- B
Takahashi K.
# \0 n2 ?; ^+ F+ e& }, A, `! u/ d$ s; u- i
Center for iPS cell Research and Application, Institute for Integrated Cell-Material Sciences, Kyoto University, Sakyo-ku, Kyoto, Japan. takahash@cira.kyoto-u.ac.jp
6 k" v0 q" i) Xhttp://www.ncbi.nlm.nih.gov/pubmed/202982606 _( P5 @" _& Q2 H$ J0 c) M
: P3 m4 F! j4 d) q! r2 o
6.Nature. 2009 Oct 1;461(7264):649-3.
7 P; B- H1 | f8 r0 _! \Direct reprogramming of human neural stem cells by OCT4.( t- ~$ T4 ]# l7 v
Kim JB, Greber B, Araúzo-Bravo MJ, Meyer J, Park KI, Zaehres H, Schöler HR.- K, q$ P1 M J5 u; b
% E5 l- \3 M9 B* A3 UMax Planck Institute for Molecular Biomedicine, Department of Cell and Developmental Biology, Röntgenstrasse 20, 48149 Münster, NRW, Germany.& W9 G5 B7 T1 \9 u1 n+ d
http://www.ncbi.nlm.nih.gov/pubmed/19718018
1 z" b% Z# T9 w$ D- [
6 G; E- ~8 j5 `0 m9 U3 q7.Blood. 2009 Aug 27;114(9):1764-7. Epub 2009 Jun 29.7 y8 o' a" d& R- [& t" h
Definitive proof for direct reprogramming of hematopoietic cells to pluripotency.- R: G$ ]4 {$ c4 ~3 u
Okabe M, Otsu M, Ahn DH, Kobayashi T, Morita Y, Wakiyama Y, Onodera M, Eto K, Ema H, Nakauchi H.
, v! j/ T3 F' _+ _7 p
: H! d$ S. Q0 V8 @Division of Stem Cell Therapy, Center for Stem Cell and Regenerative Medicine, Institute of Medical Science, University of Tokyo, Tokyo, Japan.; F W" i) @: {( \; a, [
http://www.ncbi.nlm.nih.gov/pubmed/19564635
/ |; }: b' p" X; E9 @8 S$ X) i6 O0 G* d5 G- i4 l9 a3 z1 l7 o
8.Cell Biol Int. 2009 Dec;33(12):1268-73. Epub 2009 Jun 12.
& f7 t/ T) g) ~, \; t8 QRole of MEF feeder cells in direct reprogramming of mousetail-tip fibroblasts. _8 K9 [) Y+ O/ ?; p+ o
Chen M, Sun X, Jiang R, Shen W, Zhong X, Liu B, Qi Y, Huang B, Xiang AP, Ge J.
2 V& W: C/ `0 ^0 l) U1 Y& p+ K0 e+ a+ f* T0 L/ x
State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou 510060, China.! _) X, B" }) W6 D" ^
http://www.ncbi.nlm.nih.gov/pubmed/19524692
; S4 W' t& I; f p3 m& H# H! ~: v2 O+ g7 Z2 s! y
9.Mol Ther. 2009 Jun;17(6):947-53. Epub 2009 Mar 31./ \& C# f& c1 {/ T7 |/ I" B
Upping the ante: recent advances in direct reprogramming.& a* c2 }& p- f! T( R
Müller LU, Daley GQ, Williams DA.) ^7 M; y" V7 E$ K) i4 a# r
) x) g3 ^! x" n4 U# X0 mDepartment of Medicine, Division of Pediatric Hematology Oncology, Children's Hospital Boston, Boston, Massachusetts 02115, USA.
! i* K' d9 E! z5 M/ s+ SComment in:2 P( D8 j1 j$ [+ C8 R1 U
* j0 N% ?- E' W0 C' f: A, S
Mol Ther. 2009 Jun;17(6):929-30.+ P) b5 a% |# C- }$ A
http://www.ncbi.nlm.nih.gov/pubmed/19337233( L, A' k: H9 ], T6 l
5 Z2 O0 {2 u8 m. J
10.Cell Stem Cell. 2008 Sep 11;3(3):346-53., v, B" |' B: j. K7 }
A drug-inducible system for direct reprogramming of human somatic cells to pluripotency.
. ~9 _& e1 X. \! m* wHockemeyer D, Soldner F, Cook EG, Gao Q, Mitalipova M, Jaenisch R.
! g I+ [- u3 v1 p! W- x$ q7 ^, F9 k
The Whitehead Institute, 9 Cambridge Center, Cambridge, MA 02142, USA.9 x3 o+ h/ p4 s# W
http://www.ncbi.nlm.nih.gov/pubmed/18786421
$ n0 y" S. ~, b8 @
3 a. W: y3 v9 h11.Nat Biotechnol. 2008 Aug;26(8):916-24. Epub 2008 Jul 1.
" e. {5 z$ a) N5 KA drug-inducible transgenic system for direct reprogramming of multiple somatic cell types.1 U: e3 h3 }7 ^& _3 t
Wernig M, Lengner CJ, Hanna J, Lodato MA, Steine E, Foreman R, Staerk J, Markoulaki S, Jaenisch R.- j( v4 `7 |2 N
: z2 O+ D- U2 Y( B0 s* pWhitehead Institute for Biomedical Research, 9 Cambridge Center, Cambridge, Massachusetts 02142, USA.5 ?1 f6 }) ^2 ]+ {5 M9 ~
http://www.ncbi.nlm.nih.gov/pubmed/185945215 i; @& o) M2 s7 r! Q
- @+ c) M; c0 Y% J
12.Nature. 2008 Jul 3;454(7200):49-55. Epub 2008 May 28.
. ^4 d9 h, k) r% N4 I, P7 |Dissecting direct reprogramming through integrative genomic analysis.
/ b4 J( `4 j* S O- PMikkelsen TS, Hanna J, Zhang X, Ku M, Wernig M, Schorderet P, Bernstein BE, Jaenisch R, Lander ES, Meissner A.
# A- f1 B. z3 c. `
; f+ O* y) K& l0 `* y$ H5 PBroad Institute of MIT and Harvard, 7 Cambridge Center, Cambridge, Massachusetts 02142, USA.
- M" C5 S/ c. ?3 |5 \http://www.ncbi.nlm.nih.gov/pubmed/18509334% R* K2 |! Q: [0 Q( P$ t: i
" u4 X3 V; A, _6 c# l13.Cell. 2008 Apr 18;133(2):250-64.
8 l7 O$ P; o$ ]0 T: |% G6 fDirect reprogramming of terminally differentiated mature B lymphocytes to pluripotency.
! r4 a/ A: @+ HHanna J, Markoulaki S, Schorderet P, Carey BW, Beard C, Wernig M, Creyghton MP, Steine EJ, Cassady JP, Foreman R, Lengner CJ, Dausman JA, Jaenisch R.( t; C3 i1 A. j0 R, O5 t
& a2 y$ r" n6 d, ?) i$ \
The Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA.8 \* y8 o# u f' |) V
http://www.ncbi.nlm.nih.gov/pubmed/18423197! p# q9 e" \8 o
1 m- g' a. l, I) z/ F
14.Cell Stem Cell. 2008 Feb 7;2(2):151-9.
1 O) @& X8 _3 [9 CSequential expression of pluripotency markers during direct reprogramming of mouse somatic cells.2 P8 _/ ~$ P* l% C
Brambrink T, Foreman R, Welstead GG, Lengner CJ, Wernig M, Suh H, Jaenisch R.
/ ~1 j- f5 P0 c3 f! C& g( L" `- n8 B N1 s/ H
Whitehead Institute for Biomedical Research, Massachusetts Institute of Technology, 9 Cambridge Center, Cambridge, MA 02142, USA.
M4 G$ Z9 o* q/ @2 ehttp://www.ncbi.nlm.nih.gov/pubmed/18371436
5 m0 r1 e% M' \* U* y: x
7 H6 u0 n* S$ J15.Cell Stem Cell. 2008 Jan 10;2(1):10-2. Epub 2007 Dec 13.+ v4 t( a# a: g' M' X
c-Myc is dispensable for direct reprogramming of mouse fibroblasts.
1 N" L/ v6 r. ^9 DWernig M, Meissner A, Cassady JP, Jaenisch R.* H2 J0 M7 @4 S' T( p
http://www.ncbi.nlm.nih.gov/pubmed/183714151 g6 s% A" p6 ?/ `. {
9 q+ R( v# B5 y8 g0 w16.Cell Stem Cell. 2007 Dec 13;1(6):593-4." j& c) h5 f/ S: a d
The first direct reprogramming of adult human fibroblasts.0 W6 l/ ?$ T0 D, L7 a
Wilmut I." O" Q" ~/ q$ k0 l
' b3 e$ y, G0 U5 oScottish Centre for Regenerative Medicine, University of Edinburgh, Edinburgh EH16 4SB, UK. ian.wilmut@ed.ac.uk
" z5 l0 g' B* z5 E5 L: k" mhttp://www.ncbi.nlm.nih.gov/pubmed/18371396
5 W1 ]3 a0 t8 }/ q" f9 T" z) S+ Y7 q9 E* V2 p1 n8 G
17.Nat Biotechnol. 2007 Oct;25(10):1177-81. Epub 2007 Aug 27.3 o+ } A9 W$ B5 } Q' b% ^3 p
Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells.1 ~6 N$ @& x1 q& I) p
Meissner A, Wernig M, Jaenisch R.
+ U5 O- G: `9 ~$ E5 A5 Q6 u3 j6 _1 X; q( V2 {- K
Whitehead Institute for Biomedical Research, Massachusetts Institute of Technology, Nine Cambridge Center, Cambridge Massachusetts 02142, USA.
# T+ b" U/ M* S) V7 k- j; E/ qhttp://www.ncbi.nlm.nih.gov/pubmed/17724450 |
|